Bagsværd, Denmark (ots/PRNewswire) - Data presented at ENDO 2021 demonstrate clinically relevant weight loss, without weight regain, in people treated with semaglutide 2.4 mg vs placebo in combination with lifestyle intervention. New results from the STEP phase 3a clinical trial programme demonstrated weight loss ...
Vaduz (ots) - A scientific consortium led by Liechtenstein scientists and entrepreneurs Lorenz Risch and Martin Risch launched the prospective "COVI-GAPP study", involving more than 1100 subjects from the Principality of Liechtenstein, in April 2020. The aim was to show whether a sensory bracelet, already used ...
Cork, Ireland (ots/PRNewswire) - Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused by Meibomian Gland Dysfunction (MGD). The well controlled and representative study was conducted across 26 ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for US-, Canada- or UK-based media Merck, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of patients with locally advanced or ...
Toronto (ots/PRNewswire) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms. The patent applications include use of medicinal mushrooms for the treatment of human cancers including breast cancer, use of combination medical ...
Brussels (ots/PRNewswire) - A major research project to shape regulation and policy on chemical safety without the use of animal testing has been launched with the aid of EUR19.3M funding from the European Commission under H2020 program. Led by the University of Birmingham and involving 15 European and US organisations, PrecisionTox aims to protect human health from ...
Basel (ots) - Innovative digital health solutions are enlarging treatment and diagnostic possibilities in telemedicine. Patients in Switzerland can now have their cough analyzed via an app on their smartphone. The results support doctors in advising and treating their patients. As the first European partner of ResApp, Medgate is integrating the acute respiratory diagnostic test ResAppDx into the Medgate app in a pilot ...
Almere, Netherlands (ots/PRNewswire) - There is a strict embargo on this press release and article until the time of its scheduled publication (March 5th, 2021 at 2pm ET). The link to the article, which will go live upon publication: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0246828 The influential open access journal PLOS ONE published an ...
Modiin, Israel (ots/PRNewswire) - The trial assesses the safety and efficacy of the IUB(TM) SEAD(TM), a disruptive treatment for AUB. In this study, 50% of the participating patients have reached the End of the Study point, demonstrating a significant reduction in bleeding, avoiding the need to undergo invasive ...
issuer: Flughafen Wien AG Postfach 1 A-1300 Wien-Flughafen phone: +43 1 7007 - 23126 FAX: +43 1 7007 - 23806 mail: investor-relations@viennaairport.com WWW: http://viennaairport.com/unternehmen/investor_relations ISIN: AT00000VIE62 indexes: stockmarkets: Wien language: ...
Amsterdam (ots/PRNewswire) - · Philips partners with European Hospitals to conduct first of its kind clinical research pilot program that aims to help reduce fear and anxiety to improve children's patient experience during MRI exams · Study will explore the effects and use of animated stories and characters, including Disney favorites, as part of Philips Ambient ...
Hitachi Medical Systems Europe Holding AG
Rotterdam, Netherlands (ots/PRNewswire) - Inspired by the light of the sun, and scientific research which proves that a new specific light can safely clean up to 99.9% of the coronavirus, Studio Roosegaarde launches the world's first Urban Sun. Daan Roosegaarde and his team of designers, external experts, and scientists challenged themselves to discover how the power ...
Darmstadt, Germany (ots/PRNewswire) - MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing Initial findings from the CLOCK-MS vaccine ...
Lausanne, Switzerland and Seongnam-si Gyeonggi-do, Republic of Korea (ots) - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (314130, CEO: Jisoo Pae, Hansoo Park), a global leading ...
Brussels (ots/PRNewswire) - · Revenue increased to EUR 5.3 billion (+9%, +8% CER[1]) net sales to EUR 5.1 billion (+8%, +7% CER) · Underlying profitability (adj. EBITDA[2]) was EUR 1.4 billion (+1%, -4% CER) or 27% of revenue · R&D update: bimekizumab filed with FDA and EMA for psoriasis; timelines for late stage pipeline confirmed - despite pandemic · Financial ...
Geneva, Switzerland (ots) - Survey also shows that half of the responding countries have agreed to include dentists in their priority vaccination groups FDI World Dental Federation today called for more countries to enable dentists to administer COVID-19 vaccines after a survey of its members revealed the small ...
Brussels and Atlanta (ots/PRNewswire) - - Through this collaboration with Microsoft, UCB seeks to discover and develop medicines faster for people living with severe diseases in immunology and neurology - Microsoft will provide AI technology and applied scientists to work alongside UCB's scientists and data specialists, aiming to allow UCB to discover new correlations ...
Lausanne, Switzerland (ots/PRNewswire) - - Although essential for public health, new online survey findings show that people with self-reported rosacea* may be experiencing worsening of symptoms due to mask wearing, further increasing the daily burden for people living with this chronic skin disease - Despite ...
European Society for Medical Oncology (ESMO)
Ra'anana, Israel (ots/PRNewswire) - SMART Medical has now commenced clinical collaboration with NYU Langone Health introducing its newly FDA-cleared G-EYE® 760 Colonoscope series, based on FUJIFILM Corporation's 510(k) cleared 760 colonoscopes and operating with Fujifilm's state-of-the-art ELUXEO imaging system ...
Information Office of Beijing Municipal Government
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - Bacteria can survive antibiotic treatment even without antibiotic resistance by slowing down their metabolism and going into a type of deep sleep. A research team funded by the Swiss National Science Foundation reveals the changes bacteria undergo to reach this "persister" state. Resistant bacteria evade the effects of antibiotics by becoming less susceptible, for example by breaking the drugs down. But some ...
Rehovot, Israel (ots/PRNewswire) - Potential to receive up to $103 million in upfront and milestone payments, in addition to royalties and other payments CollPlant Biotechnologies (NASDAQ: CLGN) today announced it has entered into a worldwide exclusive development and commercialization agreement for dermal and soft ...
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, a global leader in Data-Driven Medicine, announced today a clinical research partnership initiative with the Spanish Lung Cancer Group to apply its radiomics and multimodal analysis capabilities to predict response to neoadjuvant chemoimmunotherapy ...
Stans, Switzerland (ots) - NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces the pricing of its initial public offering of 4,819,277 units at a price of ...
swissstaffing - Verband der Personaldienstleister der Schweiz